Cambridge Brain Science

Cambridge Brain Science in its round of expansion capital


Cambridge Brain Science




Emerging and High Growth Companies

Date Closed

March 2021

Lead Office



On March 1, 2021, Cambridge Brain Sciences announced it closed a new round of expansion capital from Canadian Shield Capital, a Toronto-based private equity investment firm, closely aligned to Hatch, a global engineering consultancy. This institutional financing round will allow CBS to further seize upon the secular trend in digital health, especially mental health, and the need for accurate and reliable quantified measures of brain function and brain health as provided by the CBS platform.

Cambridge Brain Sciences is an online brain health assessment platform that quantifies brain function and brain health.

Canadian Shield Capital is a long-term private equity and growth capital investor focused on identifying and leveraging major demographic, social, and macroeconomic trends.

Hatch is a global multidisciplinary management, engineering, and development consultancy.

Osler, Hoskin & Harcourt LLP advised Cambridge Brain Science with a team consisting of André Perey, Andrew Irwin (Emerging and High Growth Companies) Christine Jackson (Commercial) and Alexandra Alacchi (Corporate).